The pharmaceutical cloud computing market would allow large amounts of publicly available data on biology, medicine, technology and healthcare, to be accessed by individuals on personal devices and by companies through large data centres, through a secure platform.
The cloud could also enable the use of software programs, such as CrossBow, which is capable of analysing the entire human genome in a single day.
The exponential growth in the pharmaceutical cloud computing market has affected the amount of scientific data produced, managed and analysed over the last decade, turning biology into a data-intensive science.
The advent of genomics will change our understanding of biology and human diseases, but cloud computing must step up, to store and share this enormous amount of data.
The pharmaceutical cloud computing market has managed to change the invention, development, deployment updating and maintenance of information technology (IT) services.
While the per-unit cost of computing has decreased due to the exponential increase in the power of modern machines, the cost of managing IT infrastructure has increased over the same time period.
This is mainly due to the penetration of systems within the organization which has significantly increased the complexity of the entire infrastructure. Cloud computing promises to deliver existing as well as new functionalities of IT, coupled with a significant reduction in costs for deploying these functionalities.
For more information on the pharmaceutical cloud computing market, see the latest research: Pharmaceutical Cloud Computing Market Report
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.